One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis

BACKGROUND: This study compared 1-year risk of psychiatric hospitalization and treatment costs in commercially insured patients with bipolar disorder, treated with aripiprazole, ziprasidone, olanzapine, quetiapine or risperidone. METHODS: This was a retrospective propensity score-matched cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Edward, You, Min, Pikalov, Andrei, Van-Tran, Quynh, Jing, Yonghua
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036592/
https://www.ncbi.nlm.nih.gov/pubmed/21214937
http://dx.doi.org/10.1186/1471-244X-11-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036592/
https://www.ncbi.nlm.nih.gov/pubmed/21214937
http://dx.doi.org/10.1186/1471-244X-11-6

Ejemplares similares